TPG closes $4.6b war chest for Asian deals

The private equity firm celebrates 25 years investing in Asia with its largest Asia-focused fund to date.

TPG has closed its seventh and biggest Asia-focused private equity fundraising to date, becoming the latest major player to build up its Asian war chest in recent months.

With more than $4.6 billion in commitments, according to a statement on Monday, TPG Capital Asia VII exceeded its original target by more $100 million.

That is after Hong Kong-headquartered PAG closed its $6 billion Asia III fund in November and Hillhouse Capital closed its largest fund to date in July, raising $10.6 billion in the process.

“We are incredibly grateful for the trust placed in us by both our long-standing partners, and welcome a new group of limited partners to Asia VII,” Stephen Bamford, a partner and co-head of the US-based global buyout firm said in the statement.

TPG Capital Asia VII secured its first $100 million commitment from the New Mexico State Investment Council in January 2017.
 
And it has so far already deployed 40% of the capital across a dozen companies, according to the statement, including Baidu’s wealth management and payments platform spin-off Du Xiaoman, Healthscope’s Asian pathology business in Singapore, Malaysia and Vietnam, India’s agricultural solutions provider UPL, and ASX-listed pet care platform Greencross Limited.
 
According to a further emailed statement by a TPG spokesperson, the firm's seven Asia-focused funds with $11 billion in assets across 13 countries are diversified through four core investment sectors: financial services, healthcare, consumer goods and services, and the new economy. 

To help build out its coverage, TPG has recently hired a slew of senior executives in Asia. It appointed Chang Sun managing partner for China in September 2017, Sanghoon Lee was appointed as partner to lead the firm’s Korea business in Aug 2016 and Joel Thickins was made head of Australia in March 2016.

¬ Haymarket Media Limited. All rights reserved.

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at [email protected], or +(852) 2122 5222